Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kuntai Capsule for intestinal microecology and insulin resistance in polycystic ovary syndrome
ChiCTR2300079243Phase 4Recruiting
- Sponsor
- Hangzhou Women's Hospital
- Start
- Dec 2023
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Kuntai in polycystic ovary syndrome (PCOS) (3 arms), sponsored by Hangzhou Women's Hospital. Primary endpoints: Flora analysis in stool samples and Blood lipids. Started Dec 2023; status: recruiting.
02
Drugs
Kuntai
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on ChiCTR2300079243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300079243.